Catalyst Wire Dossier Catalyst Wire Dossier

Midostaurin

midostaurin · Novartis
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Midostaurin, covering 2013-07-23 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML [Phase 2]

See pricing